RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

MARATHON CAPITAL MANAGEMENT's Holding History (CIK: 0001213206)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 144,595 Value ($000) $591 Avg Close $4.95 Range $3.81 - $7.18
Q3 2025
Shares 139,995 Value ($000) $683 Avg Close $5.25 Range $4.45 - $7.15
Q2 2025
Shares 141,895 Value ($000) $718 Avg Close $4.91 Range $3.79 - $6.11
Q1 2025
Shares 149,845 Value ($000) $793 Avg Close $7.29 Range $5.19 - $12.36
Q4 2024
Shares 146,395 Value ($000) $990 Avg Close $6.72 Range $5.60 - $9.55
Q3 2024
Shares 181,845 Value ($000) $1,198 Avg Close $7.17 Range $5.88 - $8.73
Q2 2024
Shares 175,220 Value ($000) $1,314 Avg Close $8.72 Range $6.75 - $10.66
Q1 2024
Shares 172,545 Value ($000) $1,720 Avg Close $11.14 Range $8.68 - $15.74
Q4 2023
Shares 164,880 Value ($000) $1,626 Avg Close $7.13 Range $4.97 - $11.17
Q3 2023
Shares 170,615 Value ($000) $1,305 Avg Close $9.98 Range $6.44 - $16.75